These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24756055)

  • 1. Frequency of CYP450 enzyme gene polymorphisms in the Greek population: review of the literature, original findings and clinical significance.
    Ragia G; Giannakopoulou E; Karaglani M; Karantza IM; Tavridou A; Manolopoulos VG
    Drug Metabol Drug Interact; 2014; 29(4):235-48. PubMed ID: 24756055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 pharmacogenetics in African populations.
    Alessandrini M; Asfaha S; Dodgen TM; Warnich L; Pepper MS
    Drug Metab Rev; 2013 May; 45(2):253-75. PubMed ID: 23590174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 in Cancer Susceptibility and Treatment.
    Mittal B; Tulsyan S; Kumar S; Mittal RD; Agarwal G
    Adv Clin Chem; 2015; 71():77-139. PubMed ID: 26411412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 variations in different ethnic populations.
    McGraw J; Waller D
    Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):371-82. PubMed ID: 22288606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome p450 enzyme polymorphism frequency in indigenous and native american populations: a systematic review.
    Jaja C; Burke W; Thummel K; Edwards K; Veenstra DL
    Community Genet; 2008; 11(3):141-9. PubMed ID: 18376110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 genetic polymorphisms of Mexican indigenous populations.
    Sosa-Macías M; Llerena A
    Drug Metabol Drug Interact; 2013; 28(4):193-208. PubMed ID: 24145057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of cytochrome P450 genetic polymorphism--part I. Enzymatic system of cytochrome P450 and cytochrome P450 1A2].
    Duricová J; Grundmann M
    Ceska Slov Farm; 2011 Jun; 60(3):110-5. PubMed ID: 21838140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of drug-metabolizing enzyme hydroxylation phenotypes in Hispanic populations: the CEIBA cocktail.
    de Andrés F; Sosa-Macías M; Lazalde-Ramos BP; Naranjo ME; Tarazona-Santos E; Llerena A;
    Drug Metabol Drug Interact; 2013; 28(3):135-46. PubMed ID: 23787463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: The prevalence and clinical relevance of cytochrome P450 polymorphisms.
    Wijnen PA; Op den Buijsch RA; Drent M; Kuijpers PM; Neef C; Bast A; Bekers O; Koek GH
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():211-9. PubMed ID: 18081664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ethnic background related pharmacological differences].
    Reinbold H
    MMW Fortschr Med; 2007 Oct; 149(42):34, 36. PubMed ID: 17987717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphic cytochrome P450 enzymes and post-marketing drug dosage revisions: clinical relevance to dermatologic therapies.
    Saggar S; Maibach HI
    Cutan Ocul Toxicol; 2007; 26(3):171-80. PubMed ID: 17687682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP450 pharmacogenetics for personalizing cancer therapy.
    van Schaik RH
    Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer pharmacogenomics: achievements in basic research.
    Nakajima M; Yokoi T
    Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.
    Ingelman-Sundberg M
    Trends Pharmacol Sci; 2004 Apr; 25(4):193-200. PubMed ID: 15063083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpreting and applying CYP450 genomic test results to psychotropic medications.
    Caley CF
    J Pharm Pract; 2011 Oct; 24(5):439-46. PubMed ID: 21940601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of two variants of CYP450 oxidoreductase on the stable dose of acenocoumarol in a Spanish population.
    Tong HY; Borobia AM; Martínez Ávila JC; Lubomirov R; Muñoz M; Blanco Bañares MJ; Hernández R; Fernández Capitán C; Ramírez E; Frías J; Carcas AJ
    Pharmacogenomics; 2017 Jun; 18(8):797-805. PubMed ID: 28592191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relationship of cytochrome P450 isoforms with the efficacy and safety of antipsychotic and antidepressant therapy].
    Bairamova SP; Pavlova OV; Shport SV; Gurina OI; Pavlov KA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(11):40-46. PubMed ID: 37994887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism of CYP450 and cancer susceptibility.
    Han XM; Zhou HH
    Acta Pharmacol Sin; 2000 Aug; 21(8):673-9. PubMed ID: 11501173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidance of pharmacotherapy in a complex psychiatric case by CYP450 DNA typing.
    Landino J; Buckley J; Roy JM; Villagra D; Gorowski K; Kocherla M; Windemuth A; Ruaño G
    J Am Acad Nurse Pract; 2011 Sep; 23(9):459-63. PubMed ID: 21899640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.